@scorpiomo It surprises me you say $1.3 is not peanuts for an MSB share post FDA approval!!! That defies everything stock market and everything small cap which pivots around the fact that the value of a stock is based on what potential is realises at any given time, and not compared to when for example the molecule was found!
$1.3 is absolute peanuts! In fact may be just the shell of a peanut! Look at what value a company has attracted from big pharma at that (post FDA approval) stage and ask yourself will you want a situation whereby a $1.3 easy cash worth looking falling for .... again unless there is method in the madness in terms of giving the shares away to GG.
Ann: Mesoblast Option to Issue up to US$50m Convertible Notes, page-236
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.040(3.42%) |
Mkt cap ! $1.381B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $5.683M | 4.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 19746 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |